Centre Testing International Group Co. Ltd.

Informe acción SZSE:300012

Capitalización de mercado: CN¥22.3b

Centre Testing International Group Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Centre Testing International Group de 14.6% y 11.9% por año respectivamente. Se prevé que el BPA crezca en un 14.2% al año. Se espera que la rentabilidad financiera sea de 14.4% en 3 años.

Información clave

14.6%

Tasa de crecimiento de los beneficios

14.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Professional Services27.1%
Tasa de crecimiento de los ingresos11.9%
Rentabilidad financiera futura14.4%
Cobertura de analistas

Good

Última actualización18 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Apr 21
Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Recent updates

We Think Centre Testing International Group (SZSE:300012) Can Stay On Top Of Its Debt

Nov 21
We Think Centre Testing International Group (SZSE:300012) Can Stay On Top Of Its Debt

Centre Testing International Group Co. Ltd.'s (SZSE:300012) Price Is Right But Growth Is Lacking After Shares Rocket 33%

Oct 13
Centre Testing International Group Co. Ltd.'s (SZSE:300012) Price Is Right But Growth Is Lacking After Shares Rocket 33%

The Returns At Centre Testing International Group (SZSE:300012) Aren't Growing

Sep 24
The Returns At Centre Testing International Group (SZSE:300012) Aren't Growing

Little Excitement Around Centre Testing International Group Co. Ltd.'s (SZSE:300012) Earnings

Aug 28
Little Excitement Around Centre Testing International Group Co. Ltd.'s (SZSE:300012) Earnings

A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Aug 05
A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Investors Met With Slowing Returns on Capital At Centre Testing International Group (SZSE:300012)

Jun 04
Investors Met With Slowing Returns on Capital At Centre Testing International Group (SZSE:300012)

Centre Testing International Group's (SZSE:300012) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Centre Testing International Group's (SZSE:300012) Shareholders Will Receive A Bigger Dividend Than Last Year

At CN¥12.48, Is It Time To Put Centre Testing International Group Co. Ltd. (SZSE:300012) On Your Watch List?

May 13
At CN¥12.48, Is It Time To Put Centre Testing International Group Co. Ltd. (SZSE:300012) On Your Watch List?

Earnings Troubles May Signal Larger Issues for Centre Testing International Group (SZSE:300012) Shareholders

Apr 25
Earnings Troubles May Signal Larger Issues for Centre Testing International Group (SZSE:300012) Shareholders

Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Apr 21
Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Mar 28
A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Is Centre Testing International Group (SZSE:300012) A Risky Investment?

Mar 14
Is Centre Testing International Group (SZSE:300012) A Risky Investment?

Returns On Capital Are Showing Encouraging Signs At Centre Testing International Group (SZSE:300012)

Feb 28
Returns On Capital Are Showing Encouraging Signs At Centre Testing International Group (SZSE:300012)

Previsiones de crecimiento de beneficios e ingresos

SZSE:300012 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20267,7131,2666971,67913
12/31/20256,8411,1275771,50015
12/31/20246,1039635811,35315
9/30/20245,919916342991N/A
6/30/20245,838919361977N/A
3/31/20245,679898371977N/A
12/31/20235,6059104691,122N/A
9/30/20235,5979803641,054N/A
6/30/20235,5099704651,159N/A
3/31/20235,3409275051,174N/A
1/1/20235,1319034581,100N/A
9/30/20224,9338564541,080N/A
6/30/20224,6928063971,000N/A
3/31/20224,475766388997N/A
1/1/20224,3297465121,073N/A
9/30/20214,2307334461,000N/A
6/30/20214,0376873871,033N/A
3/31/20213,8736644521,066N/A
12/31/20203,568578385931N/A
9/30/20203,328514379888N/A
6/30/20203,191509355760N/A
3/31/20203,074444234665N/A
1/1/20203,183476349795N/A
9/30/20193,051469282699N/A
6/30/20192,923379384785N/A
3/31/20192,798340320708N/A
12/31/20182,681270239684N/A
9/30/20182,538195-80477N/A
6/30/20182,358145N/A293N/A
3/31/20182,191106N/A322N/A
12/31/20172,118134N/A349N/A
9/30/20171,998127N/A413N/A
6/30/20171,866125N/A431N/A
3/31/20171,768113N/A390N/A
12/31/20161,652102N/A363N/A
9/30/20161,506181N/A281N/A
6/30/20161,391158N/A250N/A
3/31/20161,312170N/A228N/A
12/31/20151,288181N/A277N/A
9/30/20151,155137N/A241N/A
6/30/20151,077135N/A235N/A
3/31/2015991138N/A240N/A
12/31/2014926146N/A252N/A
9/30/2014853132N/A232N/A
6/30/2014823143N/A203N/A
3/31/2014800142N/A223N/A
12/31/2013777150N/A238N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.6% al año) de 300012 es superior a la tasa de ahorro (2.8%).

Beneficios vs. Mercado: Se prevé que los beneficios (14.6% al año) de 300012 crezcan menos que el mercado CN (26.3% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de 300012 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (11.9% al año) de 300012 crezcan más despacio que el mercado de CN (13.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11.9% al año) de 300012 crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 300012 sea baja dentro de 3 años (14.4%).


Descubre empresas en crecimiento